Efficacy and Safety of Hexaminolevulinate Fluorescence Cystoscopy in the Diagnosis of Bladder Cancer.
10.4111/kju.2012.53.12.821
- Author:
Jae Seung LEE
1
;
Seo Yeon LEE
;
Woo Jung KIM
;
Seong Il SEO
;
Seong Soo JEON
;
Hyun Moo LEE
;
Han Yong CHOI
;
Byong Chang JEONG
Author Information
1. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. bc2.Jung@samsung.com
- Publication Type:Original Article
- Keywords:
Bladder cancer;
Diagnostic imaging;
Hemainolevulinate
- MeSH:
Aminolevulinic Acid;
Catheters;
Cystoscopy;
Diagnostic Imaging;
Fluorescence;
Hematuria;
Humans;
Light;
Male;
Prospective Studies;
Retention (Psychology);
Sensitivity and Specificity;
Urinary Bladder;
Urinary Bladder Neoplasms;
Urinary Tract Infections
- From:Korean Journal of Urology
2012;53(12):821-825
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The aim of this study was to evaluate the efficacy and safety of hexaminolevulinate fluorescence cystoscopy in the diagnosis of bladder cancer. MATERIALS AND METHODS: In a prospective design, we included patients who had a bladder lesion suggesting bladder cancer. Patients with massive hematuria, urethral Foley catheter insertion, chronic retention state, or urinary tract infection were excluded. After the bladder was emptied, hexaminolevulinate was gently administered into the bladder. One hour later, cystoscopy under white light and blue light was performed. After marking the lesions confirmed with white light or blue light, transurethral resection of the bladder lesion and pathologic confirmation were done. Transurethral resection of the lesions that were negative in both white and blue light was also performed. RESULTS: From April 2010 to September 2010, 30 patients were enrolled. From the total of 30 patients (25 men and 5 women; mean age, 60.4+/-9.22 years), 134 specimens were extracted. Among these, 101 specimens showed positive results by blue light cystoscopy (BLC). The sensitivity of BLC and white light cystoscopy (WLC) was 92.3% and 80.8%, respectively (p=0.021). The specificity of BLC and WLC was 48% and 49.1%, respectively (p>0.05). The positive and negative predictive values of BLC were 71.2% and 81.8%, respectively, whereas those of WLC were 72.0% and 68.6%, respectively. With WLC, 48 specimens showed negative findings, but of that group, 15 specimens (31.2%) were revealed to be malignant with BLC. There were no significant side effects in the 24 hours after the instillation of hexaminolevulinate. CONCLUSIONS: Photodynamic diagnosis with hexaminolevulinate helps to find tumors that could be missed by use of WLC only. Photodynamic diagnosis might be valuable in complete resection as well as for more accurate diagnosis of bladder tumor.
